CompletedPhase 2NCT03114020

Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gerard Turino
Principal Investigator
Gerard M Turino, MD
Mount Sinai St Lukes
Intervention
Hyaluronic Acid Inhalation Solution(drug)
Enrollment
27 enrolled
Eligibility
18-80 years · All sexes
Timeline
20172019

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03114020 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency

← Back to all trials